APHAIA

Pharmaceutical preparations for the treatment and/or prevention of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, psychic disorders and gastroenterological diseases; pharmaceutical preparations for the treatment and/or prevention of pre-diabetic conditions, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, non-alcoholic steatohepatitis, depression, motivational disorders, depressive moods, and malabsorption disorders; pharmaceutical preparations for improving mood and mental and physical wellbeing; food supplements and dietetic preparations for the treatment and/or prevention of metabolic diseases, vascular diseases, neurodegenerative diseases, skeletal diseases, psychic disorders and gastroenterological diseases; food supplements and dietetic preparations for the treatment and/or prevention of prediabetic conditions, insulin resistance, obesity, type 2 diabetes, metabolic syndrome, hyperlipidemia, non-alcoholic fatty liver steatohepatitis, depression, motivational disorders, depressive moods and malabsorption disorders; food supplements and dietetic preparations for improving mood and mental and physical well-being all of the foregoing excluding any goods that consist of, contain or are derived from cannabis, marijuana or hemp

Pharmaceutical research and development services; biochemical research and development services; medical research and development services; all of the foregoing excluding services in relation to any goods that consist of, contain or are derived from cannabis, marijuana or hemp